建立一个远程PharmD程序:一个概述和关键的外卖.
Shantanu Rao1, Melissa Bray2, Kevin Tuohy3
1College of Pharmacy, The University of Findlay, 1000 N. Main Street, Findlay, OH 45840, United States of America.
Currents in pharmacy teaching & learning
|December 3, 2025
概括
在药房教育中建立远程学习途径提供了可访问性和入学优势. 然而,为了成功实施在线课程,机构必须系统地应对新的挑战.
科学领域:
- 药房 教育 教育 药房 教育
- 在线学习在线学习
- 远程教育就是远程教育.
背景情况:
- 美国的远程药房途径成立于2001年.
- 随着COVID-19的流行,在线药房教育的采用加速了.
研究的目的:
- 突出建立成功远程药房教育途径的战略.
- 为了应对挑战,并确保在线药房教育的程序性成功.
主要方法:
- 审查自2022年以来实施的远程路径建立战略.
- 分析在远程药房教育中的挑战和成功.
主要成果:
- 远程途径可以增加不同人群获得药房教育的机会.
- 成功实施需要有系统的方法来克服新的挑战.
结论:
- 远程药房教育提供了扩大获取和解决入学机会.
- 合作和政策制定对于在线药房计划的长期成功至关重要.
相关概念视频
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
01:21Pharmacodynamics: Overview and Principles
2.7K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.7K
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
01:15Drug Dosage Regimen: Overview
4.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.3K
01:20Volume of Distribution
1.1K
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
1.1K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
135
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
135